Jing Sun
- Immunology top 0.2%
- Immunotherapy and Immune Responses 33
- Immune Cell Function and Interaction 27
- T-cell and B-cell Immunology 13
- Immune cells in cancer 11
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 19
- Immunology and Allergy top 1%
- Cell Adhesion Molecules Research 14
- Cancer Research top 2%
- Molecular Biology top 5%
-
- Platelet Disorders and Treatments 11
-
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Co-authors
- Steven Μ. AlbeldaVeena KapoorGuanjun ChengZvi G. FridlenderG. Scott WorthenSamuel KimLeona LingYouhai H. Chen
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Jing Sun
119 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Immunology 5.0k
- Oncology 3.8k
- Immunology and Allergy 540
- Cancer Research 951
- Molecular Biology 2.1k
Countries citing papers authored by Jing Sun
This map shows the geographic impact of Jing Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Sun more than expected).
Fields of papers citing papers by Jing Sun
This network shows the impact of papers produced by Jing Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Sun. The network helps show where Jing Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 17 | |
| 8 | 2022 | 9 | |
| 9 | 2020 | 11 | |
| 10 | A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumorsbreakdown → | 2016 | 420 |
| 11 | 2016 | 160 | |
| 12 | 2016 | 9 | |
| 13 | 2015 | 13 | |
| 14 | 2015 | 3 | |
| 15 | 2012 | 4 | |
| 16 | 2012 | 9 | |
| 17 | 2008 | 71 | |
| 18 | 2005 | 3 | |
| 19 | 2003 | 62 | |
| 20 | 2002 | 179 |
About Jing Sun
Jing Sun is a scholar working on Immunology, Immunology and Allergy and Oncology, having authored 120 papers that have together received 8.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (33 papers), Immune Cell Function and Interaction (27 papers), Cancer Immunotherapy and Biomarkers (19 papers), Cell Adhesion Molecules Research (14 papers), T-cell and B-cell Immunology (13 papers), Platelet Disorders and Treatments (11 papers), Immune cells in cancer (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (10 papers). The work is most often cited by research in Immunology (5.0k citations), Oncology (3.8k citations) and Immunology and Allergy (540 citations). Jing Sun has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Steven Μ. Albelda, Veena Kapoor, Guanjun Cheng, Zvi G. Fridlender, G. Scott Worthen, Samuel Kim, Leona Ling, Youhai H. Chen, Sunil Singhal and Brendan Hilliard. Their work appears in journals such as Cancer Research, PLoS ONE, OncoTargets and Therapy, Journal of Immunology Research and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.